Tuesday's Early Winners & Losers
Cytokinetics (CYTK) retreated after the South San Francisco, Calif.-based biopharmaceutical company said an interim analysis following the first stage of a two-stage phase II clinical trial for Ispinesib, its treatment for recurrent and metastatic head-and-neck squamous-cell carcinoma, determined that the drug did not satisfy the criteria for advancement to Stage 2.
The best overall response to date in the clinical trial was disease stabilization, the company said, which was observed in five of 19 patients. Ispinesib is being developed in collaboration with GlaxoSmithKline (GSK). Shares of Cytokinetics were trading down 52 cents, or 8.19%, to $5.83.
CKE Restaurants (CKR) gained after Standard & Poor's said the Carpinteria, Calif.-based restaurant chain will replace Ryan's Restaurant Group (RYAN) on the S&P Small-Cap 600 after the close of trading on Thursday. Ryan's is being acquired by Buffets Inc. in a deal expected to close on or about that day, Standard & Poor's said. Shares were climbing 43 cents, or 2.57%, to $17.15.
Bright Horizons Family Solutions (BFAM) rose after Standard & Poor's said the Watertown, Mass.-based company will replace FileNet (FILE) on the S&P Small-Cap 600 after the close of trading on a date to be announced. FileNet is being acquired by IBM (IBM) in a deal awaiting final approval. Shares were climbing 77 cents, or 1.91%, to $41.06.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV